FewerJobs.
All jobs

Scientist, Radioconjugation

Regeneron Pharmaceuticals - TARRYTOWN

Posted Nov 16, 2026

Benefits

Parental leave
12 weeks From the posting source
Non-birth-parent leave
12 weeks From the posting source
Family-building benefits
  • Fertility benefits: Not verified
  • Adoption assistance: Not verified
  • Surrogacy assistance: Not verified
Mental health support
Not verified
Relocation assistance
Not verified
Childcare support
Not verified
Learning budget
Not verified
Verification
Source-linked checked May 7, 2026
Salary
$96K-$156K From the posting source
401(k) match
Reported from DOL Form 5500 industry filing (not employer-specific)

Was this benefit information wrong? Tell us.

Role

Seniority
Mid From the posting source

Schedule

Shift type
Not verified
Weekend work
Not verified

Company

Equity
Offered Verified - SEC 10-K source

Application

Cover letter
Not verified
Assessment
Not verified
Deadline
Not stated

Where they hire

State eligibility is not yet verified.

About this role

Scientist, Radioconjugation TARRYTOWN Build our future together At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. As a Scientist in Therapeutic Proteins - Antibody Radioconjugates Technology, you will play a critical role in advancing preclinical imaging and radiotherapeutic programs across multiple therapeutic areas. You will independently design, execute, and improve antibody bioconjugation and radiolabeling workflows, generating high-quality imaging and therapeutic tracers that enable quantitative evaluation of candidate therapies. Your expertise will directly support studies in Oncology, Immuno-Oncology, Infectious Disease, Inflammation, Metabolic Disease, and beyond, helping scientists better understand biodistribution, target engagement, pharmacokinetics, and therapeutic potential. When & where Location: Tarrytown, NY Work Model: On-site 5 days per week Discover your role Lead the planning and execution of antibody bioconjugation and radiolabeling campaigns to support preclinical imaging and therapeutic studies. Perform conjugation of antibodies and alternative antibody formats with bifunctional chelating agents and fluorescent probes. Develop, optimize, qualify, and document novel conjugation and radiolabeling methods for new chelators and radionuclides. Characterize bioconjugates using analytical techniques including SE-HPLC, SDS-PAGE, Western blotting, and UV/Vis spectroscopy. Generate and purify radiolabeled therapeutics and imaging tracers using radionuclides such as Cu-64, Zr-89, Lu-177, and Ac-225. Own product quality control, release testing, data interpretation, and root cause investigations for out-of-trend results. Design and execute cell-based assays to evaluate binding, potency, cytotoxicity, and mechanism of action for radioconjugate candidates. Collaborate with imaging scientists and cross-functional project teams while leading technical initiatives, maintaining compliance records, and mentoring colleagues on specialized laboratory methods.

Read the full description at regeneron.wd1.myworkdayjobs.com. FewerJobs shows a preview and links to the original posting.

Apply at regeneron.wd1.myworkdayjobs.com

Apply link verified; last checked Nov 20, 2026.

What verified means

Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.

Related jobs